Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL8, also known as Interleukin-8 (IL-8), is a chemokine produced by various cell types. It plays a central role in mediating inflammatory responses and acts primarily as a chemoattractant for neutrophils but also affects basophils and T-cells. It is associated with various diseases including Adult Respiratory Distress Syndrome, Melanoma, and Systemic Inflammatory Response Syndrome. Overproduction contributes to chronic inflammation and cancer.
Activates G-protein signaling cascades, triggers release of βγ subunits from Gαi proteins, activates downstream effectors such as PI3K/Akt pathway and MAPK pathway leading to cytoskeletal rearrangement/migration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C Motif Chemokine Ligand 8 (CXCL8).